Product NewsLonza Launches New TheraPEAK™ SfAAV™ Medium to Boost and Optimize the Production of AAV in Sf9 Insect CellsMarch24th,2020by LonzaTheraPEAK™ SfAAV™ Medium is specifically designed to support the development of safe, scalable, life-saving gene therapies
